(Q81763008)
Statements
Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn's disease (English)
R L West
Z Zelinkova
G J Wolbink
E J Kuipers
P C F Stokkers
C J van der Woude
8 August 2008
scientific article published on 08 August 2008